Skip to search.
 FTSE 100 Down 0.46%

Kite Pharma, Inc. (KITE)

-NasdaqGS
52.85 Up 0.54(1.03%) 22 May 21:00
Add to Portfolio
Prev Close:52.31
Open:52.31
Bid:51.50 x 300
Ask:65.00 x 100
1y Target Est:83.00
Beta:N/A
Next Earnings Date:N/A
Day's Range:51.66 - 53.21
52wk Range:21.00 - 89.21
Volume:1,100,849
Avg Vol (3m):1,240,750
Market Cap:2.37b
P/E (ttm):N/A
EPS (ttm):-1.91
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KITEUp 1.03%2.37b
CELGDown 0.09%92.08b
NVSDown 0.90%251.35b
PFEDown 0.23%211.08b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.76
Quarterly EPS Est (Jun-15) :-0.40
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback